Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Kaneka Pharma America, LLC
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Preeya Noronha Pinto | Deputy GC, Principal Deputy GC, Acting GC, HHS |
| Allison F. Kassir | Staff, Rep. McHale, OSD/DOD & House Armed Services Committee |
| William Clarkson | Leg. Asst. Sen. Collins; Staff Asst. Sen. Coverdell |
| Jeannine Bender | Staff, Rep. Barton |
| Michael A. Andrews | Member, U.S. House of Representatives, 1980-1994 |
| Ander Crenshaw | U.S. Representative (FL-04), 2001-2017 |
| Scott Dziengelski | Rep. Murphy (PA-18): Leg. Dir. (2015-2017), Sr. Leg. Asst.(2013-2015), Leg. Asst. (2012-2013), Leg. Corr. (2011-2012),Staff Asst. (2010-2011); Energy and Commerce Committee:Staff (2015-2017) |
| David J. Farber | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Amendment
Q2 Report
Q1 Report
Q4 Report
Amendment
Q3 Report
Amendment
Q2 Report
Registration
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate